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ABSTRACT
Objectives. This study was aimed at 
determining the prevalence of ultra-
sound (US) morpho-structural changes 
in the shoulders of patients with crys-
tal-related arthropathies, and at inves-
tigating the relationship between them 
and the clinical findings.
Methods. Eighty-eight patients with a 
crystal proven diagnosis of gout or cal-
cium pyrophosphate dihydrate (CPPD) 
disease attending the in-patient and 
the out-patient clinics of four Italian 
Rheumatology Departments were con-
secutively enrolled in this multi-centre 
study. All patients were clinically exam-
ined by an expert rheumatologist who 
recorded clinical and laboratory data 
in addition to the presence/absence of 
spontaneous shoulder pain and per-
formed the Hawkins, Jobe, Patte, Ger-
ber, and Speed tests. In each centre, 
US examinations were carried out by a 
rheumatologist expert in musculoskel-
etal US blinded to clinical data, using 
a MyLab twiCE xvg machine (Esaote 
SpA, Genoa, Italy) equipped with a 
linear probe operating at 4–13 MHz, 
and a Logiq 9 machine (General Elec-
trics Medical Systems, Milwaukee, WI, 
USA) with a linear probe operating at 
9–14 MHz. Shoulders were scanned to 
detect peri-articular inflammation, ro-
tator cuff pathology and joint involve-
ment, and to reveal US signs indicative 
of crystal deposits.
Results. A total of 88 patients, 39 with 
gout, 46 with CPPD disease, and 3 with 
both gout and CPPD disease, were 
enrolled. In total, 176 shoulders were 
clinically assessed, of which 54/176 
(30%) were painful and 74/176 (42%) 
were clinically normal shoulders. All 
US findings indicative of peri-articular 
synovial inflammation were more fre-
quently detected in patients with CPPD 
disease than in gouty patients. In 50 
out of 176 (28.4%) shoulders, US al-
lowed the detection of at least one find-
ing indicative of synovial inflamma-
tion. Chronic tendinopathy was a fre-
quent US finding both in gout patients 
and in patients with CPPD disease 
and the supraspinatus tendon was the 
most frequently involved one. In CPPD 
disease the supraspinatus tendon was 
found ruptured in a number of shoul-
ders seven times higher than in gouty 
patients. The osteophytes were found 
at acromion-clavicular joint in nearly 
80% of the shoulders in CPPD disease 
and in 60% in the gouty patients.
Conclusion. The results of this study 
confirm the high specificity of US find-
ings indicative of crystal deposits at 
hyaline cartilage level and indicate that 
the supraspinatus tendon and the fibro-
cartilage of the acromion-clavicular 
joint are the most frequently affected 
structures of the shoulders in patients 
with crystal-related arthropathies.
Introduction
Painful shoulder is a frequent com-
plaint in the general population (with 
a prevalence ranging between 17 and 
20%) and it is the commonest soft-tis-
sue disorder for referral to the general 
practitioner (1-4). Nevertheless, until 
now the evaluation of this anatomic 
site has been relatively neglected in 
patients affected by gout and calcium 
pyrophosphate dihydrate (CPPD) dis-
ease, because its involvement does not 
immediately evocate the clinical suspi-
cion of these crystalline arthropathies.
At present, there is solid body of evi-
dence supporting the use of ultrasound 
(US) in the daily practice, as an imag-
ing tool allowing for a rapid and ac-
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curate detection of several abnormali-
ties involving joint and peri-articular 
shoulder structures (5-9).
In general, US findings supplement 
the clinical picture revealing subclini-
cal soft tissue involvement (10-12). 
In patients with painful shoulder, US 
provides a detailed description of even 
minimal morphological and echotex-
tural changes usually affecting multiple 
anatomic structures of the shoulder (13-
15). In patients with crystal-related ar-
thropathies, US can identify crystal de-
posits, especially at cartilage level, and 
US findings ha shown a high degree of 
specificity and sensitivity (16-21).
This study was aimed at determining 
the prevalence of US morpho-structural 
changes in the shoulders of patients 
with definite diagnosis of gout and 
CPPD disease, and at investigating the 
relationship between US and the clini-
cal findings.
Methods
Clinical assessment
A total of 88 consecutive patients with 
either gout or CPPD disease attending 
the in-patient and the out-patient clin-
ics of four Italian Rheumatology De-
partments were enrolled in this multi-
centre study. The diagnoses were made 
according to the international criteria 
of the American Rheumatism Associa-
tion guidelines for gout and to McCarty 
criteria for CPPD disease (22, 23). 
Patients with a history of shoulder sur-
gery or severe trauma were excluded 
from this study. All patients were clini-
cally examined by an expert rheuma-
tologist who recorded clinical and labo-
ratory data in addition to the presence/
absence of spontaneous shoulder pain 
and performed the Hawkins, Jobe, Patte, 
Gerber, and Speed tests (24). 
The present study was carried out ac-
cording to local regulations and the 
Declaration of Helsinki. All patients 
gave their informed consent before 
participating in the study.
US assessment
Before starting the study, all the sono-
graphers participating in this multi-cen-
tre investigation, one per each Rheuma-
tology Department, reached an agree-
ment on both the scanning technique 
and the method to use to assess the US 
findings. 
The scanning technique was defined 
according to international indications 
provided by both rheumatologists and 
radiologists experts in musculoskeletal 
US (25-28). In each centre, US exami-
nations were carried out by a rheuma-
tologist expert in musculoskeletal US, 
blinded to clinical data, using a MyLab 
Table I. Demographic and clinical characteristics. Three patients had both gout and CPPD 
disease and their data were reported together with the results obtained from the gouty 
patients.
 Gout CPPD disease Total
Number of patients  42 46 88
Gender M/F  40/2 17/29 57/31
Mean ± SD age (min-max) (years)  62.5±10.8 (39–80) 73.6±7.7 (53–89) 68.3±10.8 (39–89)
Mean ± SD disease duration 85.2±115.7 (1–564) 58.7±69.3 (1–288) 71.2±94.4 (1–564) 
   (min-max) (months) 
Disease duration (months) no. of patients no. of patients no. of patients 
     <12 6 11 17
     12–24 9 7 16
     25–60 11 14 25
    >60 16 14 30
Table II. Prevalence of spontaneous shoulder pain and results of the provocative clinical 
tests. In this table, the data acquired for the 3 patients with diagnosis of both gout and CPPD 
disease were reported together with the results obtained in the gouty patients.
 Right shoulder (n=88) Left shoulder (n=88) Total (n=176)
 Gout CPPD Gout  CPPD disease Gout CPPD 
 (n=42) disease  (n=42) disease  (n=84) disease
  (n=46)  (n=46)  (n=92)
Spontaneous shoulder 10/23.8 20/43.5 9/21.4 15/32.6 19/22.6 35/38 
  pain (n/%)
Hawkins test (n/%) 6/14.3 13/28.3 7/16.7 11/23.9 13/15.5 24/26.1 
Patte test (n/%) 5/11.9 10/21.7 5/11.9 9/19.6 10/11.9 19/20.7
Jobe test (n/%) 5/11.9 15/32.6 6/14.3 8/17.4 11/13.1 23/25
Gerber test (n/%)  4/9.5 9/19.6 3/7.1 7/15.2 7/8.3 16/17.4
Speed test (n/%)  6/14.3 13/28.3 2/4.7 7/15.2 8/9.5 20/21.7
Palpation at acromion- 9/21.4 11/23.9 10/23.8 12/26.1 19/22.6 23/25
  clavicular joint (n/%) 
Table III. Prevalence of US findings indicative of peri-articular soft-tissue inflammation. 
In this table, the data acquired for the 3 patients with diagnosis of both gout and CPPD 
disease were reported together with the results obtained in the gouty patients.
 Right shoulder (n=88) Left shoulder (n=88) Total (n=176)
 Gout CPPD Gout CPPD Gout CPPD 
 (n=42) disease (n=42) disease (n=84) disease
  (n=46)   (n=46)   (n=92)
Long head of biceps tendon      
Synovial effusion (n/%) 10/23.8 15/32.6 6/14.3 3/6.5 16/19 18/19.6
Synovial hypertrophy (n/%) 1/2.4 4/8.7 1/2.4 2/4.3 2/2.4 6/6.5
Power Doppler signal (n/%) 1/2.4 4/8.7 1/2.4 1/ 2.2 2/2.4 5/5.4
Subdeltoid bursa      
Synovial effusion (n/%) 5/11.9 14/30.4 3/7.1 10/21.7 8/9.5 24/26.1
Synovial hypertrophy (n/%) – 6/13 – 3/6.5 – 9/9.8
Power Doppler signal (n/%) – 2/4.3 – – – 2/2.2
Subscapularis bursa      
Synovial effusion (n/%) – 3/6.5 – 2/4.3 – 5/5.4
Synovial hypertrophy (n/%) – – – – – –
Power Doppler signal (n/%) – – – – – –
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twice xvg machine (Esaote SpA, 
Genoa, Italy) equipped with a multi-fre-
quency linear probe operating at 4–13 
MHz, and a Logiq 9 machine (General 
Electrics Medical Systems, Milwaukee, 
WI, USA) with a linear probe operating 
at 9–14 MHz. Particular attention was 
paid on using all the technical aspects 
necessary to simplify the detection of 
US signs indicative of crystal deposits 
and to avoid their overestimation related 
to misinterpretation and pitfalls (29). 
Shoulders were scanned to detect peri-
articular inflammation, rotator cuff 
pathology and joint involvement (28, 
30). Moreover, the following US signs 
indicative of crystal deposits were in-
vestigated: the hyperechoic enhance-
ment of the chondro-synovial interface 
and the hyperechoic spots within both 
the fibrocartilage (i.e. the fibrocartilage 
of the acromion-clavicular joint and the 
fibrocartilage labrum within the gleno-
humeral joint) and the hyaline cartilage 
of the humeral head (31).
Results
Clinical findings
A total of 88 patients, 39 with gout, 46 
with CPPD disease, and 3 with both 
gout and CPPD disease, were enrolled. 
The demographic and clinical features 
of this cohort of patients are reported 
in Table I.
In total, 176 shoulders were clinically 
assessed, of which 54/176 (30%) were 
painful and 74/176 (42%) were com-
pletely asymptomatic and clinically 
normal shoulders (i.e. no spontaneous 
pain, no tenderness, and no swelling).
Spontaneous shoulder pain was more 
frequently found in the dominant side 
in both gouty and CPPD patients and 
in twice the number of shoulders in 
patients with CPPD disease compared 
with those with gout.
US findings
US findings indicative of peri-articular 
synovial inflammation, rotator cuff pa-
thology and joint involvement are re-
ported in Tables III, IV and V, respec-
tively. 
All US findings indicative of peri-artic-
ular synovial inflammation were more 
frequently detected in patients with 
CPPD disease than in gouty patients. 
Synovial effusion within the subdeltoid 
bursa was the most frequent pathologic 
finding in patients with CPPD disease 
and was found in 24/92 of shoulders 
(26%). 
In 50 out of 176 (28.4%) shoulders, US 
enabled the detection of at least one 
finding indicative of synovial inflam-
mation. Of these 50 shoulders, only 
two were asymptomatic and clinically 
normally shoulders. 
In 126 out of 176 (71.6) shoulders, 
no US findings indicative of inflamed 
synovial tissue were found in the peri-
articular structures. Of these 126 shoul-
ders, 6 were positive for spontaneous 
pain and US could find evidence of 
synovitis at gleno-humeral joint level 
in 4 of them. 
Table IV. Prevalence of US findings indicative of rotator cuff pathology. In this table, the 
data acquired for the 3 patients with diagnosis of both gout and CPPD disease were reported 
together with the results obtained in the gouty patients.
A. Chronic tendinopathy
 Right shoulder (n=88) Left shoulder (n=88) Total (n=176)
 Gout CPPD Gout CPPD Gout CPPD 
 (n=42) disease  (n=42) disease (n=84) disease
   (n=46)   (n=46)   (n=92)
Supraspinatus tendon (n/%) 25/59.5 29/63 19/45.2 30/65.2 44/50 59/64.1
Infraspinatus tendon (n/%) 7/16.7 12/26.1 7/16.7 13/28.7 14/16.7 25/27.2
Subscapularis tendon (n/%) 11/26.2 21/45.6 11/26.2 16/34.8 22/26.2 37/40.2
B. Intra-tendinous hyperechoic spots    
 
 Right shoulder (n=88) Left shoulder (n=88) Total (n=176)
 Gout  (n=42)      CPPD disease (n=46)      Gout  (n=42) CPPD disease (n=46) Gout  (n=84) CPPD disease (n=92) 
 P/A Acoustic P/A Acoustic P/A Acoustic P/A Acoustic P/A Acoustic P/A Acoustic 
  shadow  shadow  shadow  shadow  shadow  shadow
  (n/%)  (n/%)  (n/%)  (n/%)  (n/%)  (n/%)
Supraspinatus tendon  15/35.7 6/40 21/45.7 14/66.7 10/23.8  5/50 21/45.6 7/33.3 25/29.7 11/44 42/45.6 21/50
Infraspinatus tendon  5/11.9  3/60 5/10.9 5/100 3/7.1  3/100 9/19.6 5/55.5 8/9.5 6/75 14/15.2 10/71.4
Subscapularis tendon  3/7.1 2/66.7 10/21.7 6/60 4/9.5  1/25 10/21.7 5/50 7/8.3 3/42.8 20/21.7 11/55
P/A: Presence/Absence.
C. Rotator cuff ruptures 
 Right shoulder (n=88) Left shoulder (n=88) Total joints (n=176)
 Gout (n=42) CPPD disease (n=46) Gout (n=42) CPPD disease (n=46) Gout (n=84) CPPD disease (n=92) 
 Partial Complete Partial Complete Partial Complete Partial Complete Partial Complete Partial Complete
 tear rupture tear rupture tear rupture tear rupture tear rupture tear rupture
Supraspinatus tendon (n/%) 1/2.4 – 10/21.7  4/8.7 1/2.4 1/2.4 4/8.7 3/6.5 2/2.4 1/1.2 14/15.2 7/7.6
Infraspinatus tendon (n/%) – – – 3/6.5 1/2.4 – 2/4.3 2/4.3 1/1.2 – 2/2.2 5/5.4
Subscapularis tendon (n/%) – – 5/10.9 2/4.3 – – – 2/4.3 – – 5/5.4 4/4.3
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Chronic tendinopathy was a frequent 
US finding both in gout patients and 
in patients with CPPD disease, and the 
supraspinatus tendon was the most fre-
quently involved one. Intra-tendinous 
hyperechoic spots were also mainly 
found within the supraspinatus ten-
don, especially in patients with CPPD 
disease. Of the 41 rotator cuff ruptures 
detected by US, 24 were partial tears 
and 17 were complete ruptures. The 
supraspinatus tendon was also the most 
frequent structure showing a tendon 
rupture, and in patients with CPPD dis-
ease this tendon was found ruptured ei-
ther partially or completely in a number 
of shoulders seven times higher than in 
gouty patients (Fig. 1). 
The most frequent abnormality at the 
acromion-clavicular joint was the pres-
ence of osteophytes which was found 
in nearly the 80% of the shoulders in 
patients with CPPD disease and in 60% 
of the shoulders in the gouty patients. 
As in all peri-articular synovial cavi-
ties, also in both acromion-clavicular 
and gleno-humeral joints, synovial hy-
pertrophy and power Doppler signal at 
synovial tissue level were rare findings. 
The fibrocartilage of the acromion-cla-
vicular joint and less frequently the gle-
noid labrum showed hyperchoic spots 
especially in patients with CPPD dis-
ease (Fig. 1). The double contour sign 
was found only in three shoulders of 
two gouty patients while the presence 
of hyperechoic spots within the hyaline 
cartilage of the humeral head was de-
tected in three shoulders of three differ-
ent gouty patients and in 15 shoulders 
of 12 patients with CPPD disease.
Discussion
In the last five years, a growing number 
of rheumatologists have been using US 
to assess patients with crystal-related 
arthropathies and for guiding interven-
tional procedures in the musculoskeletal 
system (32, 33). Recent studies have 
shown the value of US in a core set of 
target sites in patients with gout and 
CPPD disease (34, 35), and other reports 
have suggested the use of US also in an-
atomic sites not considered characteris-
tic of crystal-related arthropathies (36). 
To the best of our knowledge this is the 
first study mainly aimed at investigat-
Table V. Prevalence of US findings indicative of joint involvement at shoulder level. In this 
table, the data acquired in the 3 patients with diagnosis of both gout and CPPD disease were 
reported together with the results obtained in the gouty patients.
Acromion-clavicular joint
 
 Right shoulder (n=88) Left shoulder (n=88) Total joints (n=176)
 Gout CPPD Gout CPPD Gout CPPD 
 (n=42) disease (n=42) disease (n=84) disease
  (n=46)  (n=46)   (n=92)
Synovial effusion (n/%) 11/26.2 15/32.6 9/21.4 14/30.4 20/23.8 29/31.6
Synovial hypertrophy (n/%) 3/7.1 3/6.5 2/4.7 3/6.5 5/5.9 6/6.5
Power Doppler signal (n/%) 2/4.7 – 1/2.4  – 3/3.6 –
Osteophytes (n/%) 27/64.3 38/82.6 24/57.1 35/76.1 51/60.7 73/79.3
Fibrocartilage calcification (n/%) 10/23.8 23/50 5/11.9 16/34.8 15/17.9 39/42.4
Gleno-humeral joint
 Right shoulder (n=88) Left shoulder (n=88) Total joints (n=176)
 Gout CPPD Gout  CPPD Gout CPPD
 (n=42) disease (n=42) disease (n=84) disease
  (n=46)   (n=46)   (n=92)
Synovial effusion (n/%) 3/7.1* 4/8.7* 3/7.1* 1/2.2* 6/7.1* 5/5.4*
Synovial hypertrophy (n/%) 1/2.4* 1/2.2* 1/2.4* 1/2.2* 2/2.4* 2/2.2*
Power Doppler signal (n/%) – – – – – –
Labrum calcification (n/%) 2/4.7 6/13 3/7.1 6/13 5/5.9 12/13
Humeral head - cartilage 2/4.7 7/15.2 1/2.4 8/17.4 3/3.6 15/16.3 
   calcification (n/%) 
Humeral head - double contour 1/2.4 – 2/4.7 – 3/3.6 – 
   sign (n/%) 
Bone erosions (n/%) 6/14.3 5/10.9 4/9.5 3/6.5 10/11.9 8/8.7
*posterior recess.
Fig. 1. Calcium pyrophosphate deposition disease. Patient complaining of sudden onset of severe 
shoulder pain. Ultrasound image acquired on longitudinal lateral view showing a complete rupture 
of the supraspinatus tendon. The arrow indicates a calcification of the fibrocartilage of the acromion-
clavicular joint. h: humeral head; a: acromion; c: clavicle; t: distal torn of the supraspinatus tendon; 
*: fluid in the subdeltoid bursa; d: deltoid.
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ing the prevalence of the US morpho-
structural changes in the shoulder of 
patients with definite diagnosis of gout 
and CPPD disease. 
CPPD patients complained more fre-
quently of shoulder pain, spontaneously 
and during the specific clinical maneu-
vers, than gouty patients and similarly 
US detected a higher prevalence of ro-
tator cuff pathology in CPPD disease 
than in gout. A possible explanation is 
that the former group is older than the 
latter with the consequent potential 
higher prevalence of concomitant rota-
tor cuff abnormalities.
The data obtained in this study con-
firm the ability of US in detecting, also 
in the shoulder, sonographic findings 
universally accepted as characteristic 
of monosodium urate and CPPD crys-
tal deposits. The limited sensitivity of 
some of them, especially if compared 
with the results obtained in studies per-
formed at different anatomic sites, may 
be partially related to technical aspects, 
such as the deep localisation of some 
targets (i.e. hyaline cartilage) which are 
not completely accessible.
If we exclude the osteophytes and the 
fibrocartilage involvement at the acro-
mion-clavicular joints, the results of 
this study indicates that the most fre-
quent US pathologic findings were de-
tected at supraspinatus tendon level, es-
pecially in patients with CPPD disease. 
Of note, in patients with CPPD disease 
nearly half of the scanned supraspinatus 
tendons was found positive for US find-
ings indicative of calcification, suggest-
ing that the real prevalence of the CPPD 
crystal deposits within the rotator cuff 
may be underestimated. Possible ex-
planations could be that CPPD deposits 
may be misinterpreted as basic calcium 
phosphate aggregates or that they may 
be missed because of the well-known 
limitations of the other imaging tech-
niques (i.e. x-ray and MRI) used to as-
sess the shoulder. In the interpretation of 
these results we cannot neglect the fact 
that the shoulder is a complex anatomic 
site, which includes several structures, 
some superficial and others deeper re-
quiring different acoustic windows to 
be adequately assessed. The patient’s 
body size can largely influence the US 
visualisation of the shoulder structures. 
A thick layer of subcutaneous adipose 
tissue and/or a hypertrophic deltoid 
muscle make target tissues, such as the 
humeral head hyaline cartilage, deeper 
and more difficult to scan. Moreover, 
the width of the acoustic windows de-
pends on shoulder movements which 
can be variably impaired by pain and/or 
obesity. Conversely, US assessment of 
the fibrocartilage of the acromion-clav-
icular joint can be performed with high 
frequency probes because of its super-
ficial position and does not require any 
particular shoulder positioning. 
The results of this study should be in-
terpreted in the light of the fact that all 
sonographers involved in this study 
have several years’ experience in mus-
culoskeletal US and the US systems can 
be considered in the high quality sector. 
This study has some limitations. First, 
the US findings were not compared with 
those of other imaging techniques. Sec-
ond, the study was performed using a 
probe with a relatively low frequency, 
ranging between 4 and 13 MHz, chosen 
in order to allow the detection of the gle-
no-humeral joint also in obese subjects, 
in whom the detection of power Doppler 
signal is impaired especially at superfi-
cial tissue level such as the acromion-
clavicular joint.
In conclusion, the results of this study 
confirm the high specificity of US find-
ings indicative crystal deposits at hya-
line cartilage level and indicate that the 
supraspinatus tendon and the fibrocar-
tilage of the acromion-clavicular joint 
are the most frequently affected struc-
tures of the shoulders in patients with 
crystal-related arthropathies.
References
 1. BOT SD, van der WAAL JM, TERWEE CB et 
al.: Incidence and prevalence of complaints 
of the neck and upper extremity in general 
practice. Ann Rheum Dis 2005, 64: 118-23.
  2. FELEUS A, BIERMA-ZEINSTRA SM, MIEDE-
MA HS, BERNSEN RM, VERHAAR JA, KOES 
BW: Incidence of non-traumatic complaints 
of arm, neck and shoulder in general prac-
tice. Man Ther 2008; 13: 426-33.
  3. PICAVET HS, SCHOUTEN JS: Musculoskel-
etal pain in the Netherlands: prevalences, 
consequences and risk groups, the DMC(3)-
study. Pain 2003; 102: 167-78.
  4. SALAFFI F, De ANGELIS R, GRASSI W: 
Prevalence of musculoskelatal conditions in 
Italian population sample: results of a region-
al community-based study. I. The MAPPING 
(MArche Pain Prevalence INvestigation 
Group) study. Clin Exp Rheumatol 2005; 23: 
819-28.
  5. JACOBSON JA, LANCASTER S, PRASAD A, 
van HOLSBEECK MT, CRAIG JG, KOLOWICH 
P: Full-thickness and partial-thickness su-
praspinatus tendon tears: value of US signs 
in diagnosis.Radiology 2004; 230: 234-42.
  6. MARTINOLI C, BIANCHI S, PRATO N et al.: 
US of the shoulder: non-rotator cuff disor-
ders. Radiographics 2003; 23: 381-401.
  7. IAGNOCCO A, FILIPPUCCI E, MEENAGH G et 
al.: Ultrasound imaging for the rheumatolo-
gist. I. Ultrasonography of the shoulder. Clin 
Exp Rheumatol 2006; 24: 6-11.
  8. BRUYN GA, PINEDA C, HERNANDEZ-DIAZ C 
et al.:Validity of ultrasonography and meas-
ures of adult shoulder function and reliabil-
ity of ultrasonography in detecting shoulder 
synovitis in patients with rheumatoid arthri-
tis using magnetic resonance imaging as a 
gold standard. Arthritis Care Res (Hoboken) 
2010; 62: 1079-86.
  9. NARANJO A, JIMÉNEZ-NÚÑEZ FG, MEDINA-
LUEZAS J et al.: Impact of the use of muscu-
loskeletal ultrasound by rheumatologists in 
patients with shoulder and hand complaints 
compared with traditional clinical care. Clin 
Exp Rheumatol 2012; 30: 768-71.
10. WAKEFIELD RJ, GREEN MJ, MARZO-ORTE-
GA H et al.: Should oligoarthritis be reclas-
sified? Ultrasound reveals a high prevalence 
of subclinical disease. Ann Rheum Dis 2004; 
63: 382-5.
11. SZKUDLAREK M, KLARLUND M, NARVE-
STAD E et al.: Ultrasonography of the 
metacarpophalangeal and proximal inter-
phalangeal joints in rheumatoid arthritis: a 
comparison with magnetic resonance imag-
ing, conventional radiography and clinical 
examination. Arthritis Res Ther 2006; 8: 
R52.
12. NAREDO E, BONILLA G, GAMERO F, USON J, 
CARMONA L, LAFFON A: Assessment of in-
flammatory activity in rheumatoid arthritis: a 
comparative study of clinical evaluation with 
grey scale and power Doppler ultrasonogra-
phy. Ann Rheum Dis 2005; 64: 3 75-81.
13. RIENTE L, Delle SEDIE A, FILIPPUCCI E et 
al.: Ultrasound imaging for the rheumatolo-
gist XLV. Ultrasound of the shoulder in pso-
riatic arthritis. Clin Exp Rheumatol 2013; 31: 
329-33.
14. IAGNOCCO A, FILIPPUCCI E, SAKELLARIOU 
G et al.: Ultrasound imaging for the rheuma-
tologist XLIV. Ultrasound of the shoulder 
in healthy individuals. Clin Exp Rheumatol 
2013; 31: 165-71.
15. JACOBSON JA, LANCASTER S, PRASAD A, 
van HOLSBEECK MT, CRAIG JG, KOLOWICH 
P: Full-thickness and partial-thickness su-
praspinatus tendon tears: Value of US signs 
in diagnosis. Radiology 2004; 230: 234-42.
16. WRIGHT SA, FILIPPUCCI E, McVEIGH C et 
al.: High-resolution ultrasonography of the 
first metatarsal phalangeal joint in gout: a 
controlled study. Ann Rheum Dis 2007; 66: 
859-64.
17. THIELE RG, SCHLESINGER N: Diagnosis of 
gout by ultrasound. Rheumatology 2007; 46: 
1116-21.
18. Delle SEDIE A, RIENTE L, IAGNOCCO A et 
664
IMAGING US of the shoulder in patients with gout and CPPD disease / E. Filippucci et al.
al.: Ultrasound imaging for the rheumatolo-
gist X. Ultrasound imaging in crystal-related 
arthropathies. Clin Exp Rheumatol 2007; 25: 
513-7.
19. FILIPPUCCI E, SCIRÈ CA, Delle SEDIE A et 
al.: Ultrasound imaging for the rheumatolo-
gist.XXV. Sonographic assessment of the 
knee in patients with gout and calciumpy-
rophosphate deposition disease. Clin Exp 
Rheumatol 2010; 28: 2-5.
20. FILIPPUCCI E, MEENAGH G, Delle SEDIE A 
et al.: Ultrasound imaging for the rheuma-
tologist XXXVI. Sonographic assessment of 
the foot in gout patients. Clin Exp Rheumatol 
2011; 29: 901-5.
21. OTTAVIANI S, RICHETTE P, ALLARD A, ORA 
J, BARDIN T: Ultrasonography in gout: a 
case-control study. Clin Exp Rheumatol 
2012; 30: 499-504.
22. WALLACE SL, ROBINSON H, MASI AT, DECK-
ER JL, McCARTY DJ, YU TF: Preliminary cri-
teria for the classification of the acute arthri-
tis of primary gout. Arthritis Rheum 1977; 
20: 895-900.
23. McCARTY DJ: Calcium pyrophosphate dihy-
drate crystal deposition disease. In: SCHU-
MACHER HR Jr (Ed.): Primer on the Rheu-
matic Diseases. 10th ed. Atlanta, Arthritis 
Foundation, 1993: 219.
24. SALAFFI F, CIAPETTI A, CAROTTI M et al.: 
Clinical value of single versus composite 
provocative clinical tests in the assessment 
of painful shoulder. J Clin Rheumatol 2010; 
16: 105-8.
25. BACKHAUS M, BURMESTER GR, GERBER 
T et al.: Guidelines for musculoskeletal ul-
trasound in rheumatology. Ann Rheum Dis 
2001; 60: 641-9. 
26. KLAUSER AS, TAGLIAFICO A, ALLEN GM et 
al.: Clinical indications for musculoskeletal 
ultrasound: a Delphi-based consensus paper 
of the European Society of Musculoskeletal 
Radiology. Eur Radiol 2012; 22: 1140-8.
27. JACOBSON JA: Shoulder US: anatomy, tech-
nique, and scanning pitfalls. Radiology 2011; 
260: 6-16.
28. NAREDO E, AGUADO P, De MIGUEL E et al.: 
Painful shoulder: comparison of physical 
examination and ultrasonographic findings. 
Ann Rheum Dis 2002; 61: 132-6.
29. FILIPPUCCI E, Di GESO L, GRASSI W: Tips 
and tricks to recognize microcrystalline ar-
thritis. Rheumatology (Oxford) 2012; 51 
(Suppl. 7): vii18-21.
30. WAKEFIELD RJ, BALINT PV, SZKUDLAREK 
M et al.: Musculoskeletal ultrasound includ-
ing definitions for ultrasonographic pathol-
ogy. J Rheumatol 2005; 32: 2485-7.
31. FILIPPUCCI E, RIVEROS MG, GEORGESCU D, 
SALAFFI F, GRASSI W: Hyaline cartilage in-
volvement in patients with gout and calcium 
pyrophosphate deposition disease. An ultra-
sound study. Osteoarthritis Cartilage 2009; 
17: 178-81.
32. Delle SEDIE A, RIENTE L, IAGNOCCO A et 
al.: Ultrasound imaging for the rheumatolo-
gist XLVI. Ultrasound guided injection in the 
shoulder: a descriptive literature review. Clin 
Exp Rheumatol 2013; 31: 477-83.
33. SCONFIENZA LM, BANDIRALI M, SERAFINI 
G et al.: Rotator cuff calcific tendinitis: does 
warm saline solution improve the short-term 
outcome of double-needle US-guided treat-
ment? Radiology 2012; 262: 560-6.
34. PEITEADO D, De MIGUEL E, VILLALBA A, 
ORDÓÑEZ MC, CASTILLO C, MARTÍN-MOLA 
E: Value of a short four-joint ultrasound test 
for gout diagnosis: a pilot study. Clin Exp 
Rheumatol 2012; 30: 830-7.
35. FILIPPOU G, FILIPPUCCI E, TARDELLA M et 
al.: Extent and distribution of CPP deposits in 
patients affected by calcium pyrophosphate 
dihydrate deposition disease: an ultrasono-
graphic study. Ann Rheum Dis 2013 Mar 26 
[Epub ahead of print].
36. Di GESO L, TARDELLA M, GUTIERREZ M, 
FILIPPUCCI E, GRASSI W: Crystal deposition 
at elbow hyaline cartilage: the sonographic 
perspective. J Clin Rheumatol 2011;17: 344-
5.
